bioRxiv Science⌕ Search

Biology subjects

Greiser, M.

Publications and source records attributed to Greiser, M..

3 recordsLinked to original sources

Na+/K+ATPase - Cav1.2 nanodomain differentially regulates intracellular and local adrenergic signaling in cardiac myocytes

BackgroundThe intracellular Na+ concentration ([Na+]i) is a crucial but understudied regulator of cardiac myocyte function. The Na+/K+ ATPase (NKA) controls the steady-state [Na+]i and thereby determines the set-point for intracellular Ca2+. Here, we investigate the nanoscopic organization and local adrenergic regulation of the NKA macromolecular complex and how it differentially regulates the intracellular Na+ and Ca2+ homeostases in atrial and ventricular myocytes. MethodsMulticolor STORM super-resolution microscopy, Western Blot analyses, and in vivo examination of adrenergic regulation are employed to examine the organization and function of Na+ nanodomains in cardiac myocytes. Quantitative fluorescence microscopy at high spatiotemporal resolution is used in conjunction with cellular electrophysiology to investigate intracellular Na+ homeostasis in atrial and ventricular myocytes. ResultsThe NKA1 (NKA1) and the L-type Ca2+-channel (Cav1.2) form a nanodomain with a center-to center distance of [~]65 nm in both ventricular and atrial myocytes. NKA1 protein expression levels are [~]3 fold higher in atria compared to ventricle. 100% higher atrial INKA, produced by large NKA "superclusters", underlies the substantially lower Na+concentration in atrial myocytes compared to the benchmark values set in ventricular myocytes. The NKAs regulatory protein phospholemman (PLM) has similar expression levels across atria and ventricle resulting in a much lower PLM/NKA1 ratio for atrial compared to ventricular tissue. In addition, a huge PLM phosphorylation reserve in atrial tissue produces a high {beta}-adrenergic sensitivity of INKA in atrial myocytes. {beta}-adrenergic regulation of INKA is locally mediated in the NKA1-Cav1.2 nanodomain via A-kinase anchoring proteins. ConclusionsNKA1, Cav1.2 and their accessory proteins form a structural and regulatory nanodomain at the cardiac dyad. The tissue-specific composition and local adrenergic regulation of this "signaling cloud" is a main regulator of the distinct global intracellular Na+ and Ca2+ concentrations in atrial and ventricular myocytes.

physiology↗

Arrhythmogenic Ca2+ Signaling in a Metabolic Model of HFpEF

Heart Failure with preserved ejection fraction (HFpEF) is the most prevalent form of heart failure worldwide and its significant mortality is associated with a high rate of sudden cardiac death (SCD; 30% - 40%). Chronic metabolic stress is an important driver of HFpEF, and clinical data show metabolic stress as a significant risk factor for ventricular arrhythmias in HFpEF patients. The mechanisms of SCD and ventricular arrhythmia in HFpEF remain critically understudied and empirical treatment is ineffective. To address this important knowledge gap, we developed a novel preclinical model of metabolic-stress induced HFpEF using Western diet (High fructose and fat) and hypertension induced by nitric oxide synthase inhibition (with L-NAME) in wildtype C57BL6/J mice. After 5 months, mice display all clinical characteristics of HFpEF and present with stress-induced sustained ventricular tachycardia (VT). Mechanistically, we found a novel pattern of arrhythmogenic intracellular Ca2+ handling that is distinct from the well-characterized changes pathognomonic for heart failure with reduced ejection fraction. In addition, we show that the transverse tubular system remains intact in HFpEF and that arrhythmogenic, intracellular Ca2+ mobilization becomes hyper-sensitive to {beta}- adrenergic activation. Finally, in proof-of-concept experiments we show in vivo that the clinically used intracellular calcium stabilizer dantrolene, which acts on the Ca2+ release channels of the sarcoplasmic reticulum (SR), the ryanodine receptors, acutely prevents stress-induced VT in HFpEF mice. Therapeutic control of SR Ca2+ leak may present a novel mechanistic treatment approach in metabolic HFpEF.

physiology↗

Calcium and Bicarbonate Signaling Pathways have Pivotal, Resonating Roles in Matching ATP Production to Demand

Mitochondrial ATP production in cardiac ventricular myocytes must be continually adjusted to rapidly replenish the ATP consumed by the working heart. Two systems are known to be critical in this regulation: mitochondrial matrix Ca2+ ([Ca2+]m) and blood flow that is tuned by local ventricular myocyte metabolic signaling. However, these two regulatory systems do not account for the large physiological range of ATP consumption observed. We report here on the identity, location, and signaling cascade of a controversial third regulatory system -- CO2/bicarbonate. CO2 is generated in the mitochondrial matrix as a metabolic waste product produced by oxidation of nutrients which power the production of ATP. It is a lipid soluble gas that equilibrates with bicarbonate (HCO3-) in aqueous solutions. The bicarbonate level is tracked by a bicarbonate-activated adenylyl cyclase, soluble adenylyl cyclase (sAC). Using structural Airyscan super-resolution imaging and functional measurements we find that sAC is primarily inside the mitochondria of ventricular myocytes where it generates cAMP when activated by HCO3-. This cAMP signaling cascade is shown to operate inside the mitochondrial inter-membrane space (IMS) by activating local EPAC1 (Exchange Protein directly Activated by cAMP) which turns on Rap1 (Ras-related protein 1). Thus, mitochondrial ATP production is shown to be increased by bicarbonate-triggered sAC signaling through Rap1. Additional evidence is presented indicating that the cAMP signaling itself does not occur directly in the matrix. We also show that this third signaling process involving bicarbonate and sAC activates the cardiac mitochondrial ATP production machinery by working independently of, yet in conjunction with, [Ca2+]m-dependent ATP production to meet the energy needs of cellular activity in both health and disease. Thus, the resonant, or complementary effects of bicarbonate and [Ca2+]m signaling arms tune mitochondrial ATP production to match the full scale of energy consumption in cardiac ventricular myocytes.

physiology↗